Literature DB >> 28814812

Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up.

S Cimino1, S Voce2, F Palmieri2, V Favilla1, T Castelli1, S Privitera1, R Giardina1, G Reale1, G I Russo1, G Morgia1.   

Abstract

The surgical treatment of benign prostatic obstruction is changing over the time, thanks the increase evidence about the successful role of laser techniques in this surgery. We aimed to compare prostatic GreenLight photovaporization (PVP) to bipolar transurethral resection of the prostate (TURP) with regard to lower urinary tract symptoms (LUTS) improvement through the evaluation of BPH6. We enrolled 220 consecutive subjects affected by LUTS. We performed a propensity score matching using prostate volume, peak flow and International Prostate Symptoms Score (IPSS). A total of 110 (55 TURP and 55 PVP) were analyzed. We found after 1 year of follow-up that the rate of subjects resulting in greater BPH6 recovery in the PVP group vs TURP (45.6% vs 18.2%; P=0.001). The TURP treatment showed greater catheterization time (4.67 vs 1.25; P<0.01) while PVP showed greater recovery experience (82.4 vs 58.2; <0.01). Postoperative ejaculatory dysfunctions were observed in both groups, 58.8% in TURP and 34.5% in PVP group. The multivariate logistic regression analysis, adjusted for preoperative variables, showed that PVP was independently associated with BPH6 recovery end point (odds ratio=3.77; P<0.01). This study showed data in favor of PVP. Although IPSS and peak flow improvements were similar, PVP showed better clinical outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 28814812     DOI: 10.1038/ijir.2017.30

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  28 in total

1.  Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials.

Authors:  Yan Zhou; Boxin Xue; Nadeem Ahmed Mohammad; Dong Chen; Xiaofei Sun; Jinhui Yang; Guangcheng Dai
Journal:  Lasers Med Sci       Date:  2016-02-11       Impact factor: 3.161

Review 2.  Systematic review on recovery specific quality-of-life instruments.

Authors:  Kirsten B Kluivers; Ingrid Riphagen; Mark E Vierhout; Hans A M Brölmann; Henrica C W de Vet
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

3.  Safety of greenlight photoselective vaporisation of prostate in lower urinary tract symptoms due to benign prostatic hyperplasia in patients using anticoagulants due to cardiovascular comorbidities.

Authors:  Basri Cakiroglu; Orhun Sinanoglu; Akif Nuri Dogan
Journal:  Arch Ital Urol Androl       Date:  2015-07-07

4.  Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial.

Authors:  Claus G Roehrborn; Timothy H Wilson; Libby K Black
Journal:  J Urol       Date:  2012-03-15       Impact factor: 7.450

5.  Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study.

Authors:  Giorgio Ivan Russo; Sebastiano Cimino; Eugenia Fragalà; Salvatore Privitera; Sandro La Vignera; Rosita Condorelli; Aldo E Calogero; Mario Chisari; Tommaso Castelli; Vincenzo Favilla; Giuseppe Morgia
Journal:  World J Urol       Date:  2014-09-05       Impact factor: 4.226

6.  A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighing tests.

Authors:  H Sandvik; A Seim; A Vanvik; S Hunskaar
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

7.  Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy.

Authors:  Vipul R Patel; Ananthakrishnan Sivaraman; Rafael F Coelho; Sanket Chauhan; Kenneth J Palmer; Marcelo A Orvieto; Ignacio Camacho; Geoff Coughlin; Bernardo Rocco
Journal:  Eur Urol       Date:  2011-01-25       Impact factor: 20.096

8.  Impact of prostate volume on erectile dysfunction and premature ejaculation.

Authors:  Jun Ho Lee; Sung Won Lee
Journal:  Aging Male       Date:  2016-05-05       Impact factor: 5.892

9.  Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction.

Authors:  Thorsten Bach; Felix Wölbling; Andreas J Gross; C Netsch; S Tauber; Tobias Pottek; Christian Wülfing; Claus Brunken
Journal:  World J Urol       Date:  2016-06-04       Impact factor: 4.226

10.  Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

Authors:  Raymond Rosen; Jens Altwein; Peter Boyle; Roger S Kirby; B Lukacs; Eric Meuleman; Michael P O'Leary; Paolo Puppo; Chris Robertson; Francois Giuliano
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

View more
  4 in total

1.  Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies.

Authors:  Chaohui Gu; Naichun Zhou; Pratik Gurung; Yiping Kou; Yang Luo; Yidi Wang; Hui Zhou; Cheng Zhen; Jinjian Yang; Fengyan Tian; Guan Wu
Journal:  World J Urol       Date:  2019-06-17       Impact factor: 4.226

Review 2.  Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.

Authors:  Soum D Lokeshwar; Benjamin T Harper; Eric Webb; Andre Jordan; Thomas A Dykes; Durwood E Neal; Martha K Terris; Zachary Klaassen
Journal:  Transl Androl Urol       Date:  2019-10

3.  Comparison of bipolar plasmakinetic resection of prostate versus photoselective vaporization of prostate by a three year retrospective observational study.

Authors:  Xu Cheng; Chuying Qin; Peng Xu; Yijian Li; Mou Peng; Shuiqing Wu; Da Ren; Lizhi Zhou; Yinhuai Wang
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

4.  Development of Medical Lasers for Treatment on Benign Prostatic Hyperplasia.

Authors:  Xiao-Lei Ren; Hai-Bo Xia
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.